Search Results - Jacques‐Louis Binet
- Showing 1 - 4 results of 4
-
1
-
2
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study by Michael J. Keating, Ian W. Flinn, Vinay Jain, Jacques‐Louis Binet, Peter Hillmen, John C. Byrd, Maher Albitar, Lee Brettman, P. Santabárbara, Bret Wacker, R. Kanti
Published 2002Artigo -
3
Chlorambucil in Indolent Chronic Lymphocytic Leukemia by Guillaume Dighiero, Karim Maloum, B Desablens, Bruno Cazin, Maurice Navarro, R Leblay, M Leporrier, J. Jaubert, G. Lepeu, Brigitte Dreyfus, Jacques‐Louis Binet, Philippe Travade, François-Louis Turpin, G. Tertian, Agnès Bichoffe
Published 1998Artigo -
4
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients by M Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, B Desablens, Marie‐José Rapp, J. Jaubert, Claudie Autrand, Marine Diviné, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques‐Louis Binet, Claude Chastang
Published 2001Artigo
Search Tools:
Related Subjects
Chemotherapy
Chronic lymphocytic leukemia
Cyclophosphamide
Gastroenterology
Internal medicine
Leukemia
Medicine
Surgery
Biology
Fludarabine
Prednisone
Adverse effect
Alemtuzumab
Antibody
Antigen
Astrobiology
Biochemistry
CHOP
Chemistry
Chlorambucil
Confidence interval
Environmental health
Enzyme
Immunoglobulin light chain
Immunology
Kappa
Linguistics
Lymphocyte
Lymphoma
Molecular biology